Kurdikar Devdatt 4

What Happened Devdatt Kurdikar, a member of the board of directors of Zimmer Biomet Holdings, Inc. (ZBH), was granted 154.356 phantom stock units on 2026-03-31 under the Zimmer Biomet Deferred Compensation Plan for Non-Employee Directors. The units were recorded at $0.00 (no cash payment) and are derivative awards that convert 1-for-1 into common shares. Per the plan, these units are to be settled in shares within 60 days after the director ceases service. The grant includes 4.508 additional phantom units accrued on January 30, 2026 under the plan’s dividend reinvestment provision.

Key Details

• Transaction date: 2026-03-31; Filing date: 2026-04-02 (timely filing).
• Transaction type/code: Award/Grant (A); derivative security (phantom stock units).
• Amount: 154.356 phantom stock units; Conversion/exercise ratio: 1-for-1; Reported acquisition price: $0.00.
• Settlement: Units convert to common stock and will be settled in shares within 60 days after cessation of director service.
• Footnote: 4.508 units included from dividend reinvestment (accrued 2026-01-30).
• Shares owned after the transaction: not specified in the Form 4 filing.

Context This is a routine director compensation award (deferred/phantom units), not an open-market purchase or sale. Phantom stock units are bookkeeping awards that only become actual shares upon settlement (here tied to the end of the director’s service), so this does not represent an immediate change in market exposure or a typical bullish/sell signal.